Keros Therapeutics Inc (KROS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
14.21 -0.21 (-1.46%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 14.09 -0.12 (-0.84%) 16:13 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -187,353 | -152,992 | -104,679 | -58,744 | -45,361 |
| Depreciation Amortization | 1,229 | 815 | 674 | 378 | 278 |
| Accounts receivable | -2,599 | -143 | 18,000 | -18,000 | N/A |
| Accounts payable and accrued liabilities | -249 | 1,614 | -408 | 1,485 | 61 |
| Other Working Capital | -11,437 | -2,650 | 14,308 | -16,070 | 2,275 |
| Other Operating Activity | 39,540 | 28,848 | 2,043 | 28,803 | 5,853 |
| Operating Cash Flow | $-160,869 | $-124,508 | $-70,062 | $-62,148 | $-36,894 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,931 | -2,464 | -1,241 | -1,024 | -294 |
| Investing Cash Flow | $-1,931 | $-2,464 | $-1,241 | $-1,024 | $-294 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 392,275 | 179,050 | 120,396 | 28,550 | 243,240 |
| Other Financing Activity | -454 | -94 | -87 | 0 | 52,804 |
| Financing Cash Flow | $391,821 | $178,956 | $120,309 | $28,550 | $296,044 |
| Beginning Cash Position | 332,359 | 280,375 | 231,369 | 265,991 | 7,135 |
| End Cash Position | 561,380 | 332,359 | 280,375 | 231,369 | 265,991 |
| Net Cash Flow | $229,021 | $51,984 | $49,006 | $-34,622 | $258,856 |
| Free Cash Flow | |||||
| Operating Cash Flow | -160,869 | -124,508 | -70,062 | -62,148 | -36,894 |
| Capital Expenditure | -1,931 | -2,464 | -1,241 | -1,024 | -294 |
| Free Cash Flow | -162,800 | -126,972 | -71,303 | -63,172 | -37,188 |